Amyotrophic Lateral Sclerosis (ALS)

ALS: BrainStorm to Test NurOwn Cells in US

Tirasemtiv May Slow Respiratory Decline in ALS

ALS: Experimental Drug Tirasemtiv Fails To Show Efficacy in Phase 2b Trial



Shape of Genetic Material Matters in C9ORF72-Related ALS

Dutch Bros. Coffee Annual “Drink One for Dane” Day to Donate Proceeds to Muscular Dystrophy Association

Leading the Way: MDA’s critical support for people with ALS

For many, amyotrophic lateral sclerosis is a fast disease. Once diagnosed, the average life expectancy for a person with ALS can be as few as three to five years. When Ben Thomas received his ALS diagnosis at the age of 29 — just three months after the birth of his only daughter, Emmerson — his world was turned upside down.

MDA is the world leader in funding ALS research and services.

New Forms of Genetic Testing Improve Diagnosis, Raise Questions

“Knowing, if not all, is almost all,” said Matthew Harms, a neurologist and neurophysiologist from Washington University in St. Louis, in his presentation on genetic testing for neuromuscular disorders at the 2014 MDA Clinical Conference, held in Chicago March 16-19.

Fierce Hope


Ray created “Fierce Hope” specifically for the MDA Art Collection. He began creating artwork after he was diagnosed with ALS in 2011. Ray uses pastels and holds them between two fingers on one hand guided with the other hand. Some of his artwork has taken as long as nine hours to complete. One of his favorite quotes is “I am not counting my days – I am making my days count.”

Raymond West

Full name: 
Mr. Raymond West
Raymond West
Amyotrophic Lateral Sclerosis (ALS)

ALS-Causing Mutations Impair TDP43 Transport in Nerve Cells